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Abstract. Although prospective logistic regression is the standard method
of analysis for case-control data, it has been recently noted that in genetic
epidemiologic studies one can use the “retrospective” likelihood to gain
major power by incorporating various population genetics model assump-
tions such as Hardy–Weinberg-Equilibrium (HWE), gene–gene and gene–
environment independence. In this article we review these modern meth-
ods and contrast them with the more classical approaches through two
types of applications (i) association tests for typed and untyped single nu-
cleotide polymorphisms (SNPs) and (ii) estimation of haplotype effects and
haplotype–environment interactions in the presence of haplotype-phase am-
biguity. We provide novel insights to existing methods by construction of
various score-tests and pseudo-likelihoods. In addition, we describe a novel
two-stage method for analysis of untyped SNPs that can use any flexible ex-
ternal algorithm for genotype imputation followed by a powerful association
test based on the retrospective likelihood. We illustrate applications of the
methods using simulated and real data.
Key words and phrases: Case-control studies, Empirical-Bayes, genetic
epidemiology, haplotypes, model averaging, model robustness, model selec-
tion, retrospective studies, shrinkage.
1. INTRODUCTION
Case-control study designs are now widely used to
study the role of genetic susceptibility in the etiol-
ogy of rare complex diseases. Typically, a case-control
study involves recruiting all or a large fraction of the
diseased subjects (cases) that arise in an underlying
study base and then sampling a comparable number of
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healthy subjects (controls), ideally from the exact same
study base, and possibly matched with the cases by
some socio-demographic characteristics such as race,
age and gender. Biological samples and questionnaire
data collected on the sampled subjects are then used
to determine their genetic susceptibility, such as SNP
genotypes and history of some nongenetic (environ-
mental) exposures. For rare diseases such as cancers,
case-control studies are cost-efficient compared to a
cross-sectional or prospective cohort studies because
they dramatically reduce the number of nondiseased
subjects to study.
In general, the standard method for analysis of case-
control data is the prospective logistic regression ignor-
ing the retrospective nature of the underlying design.
The validity of this approach relies on the classic re-
sults by Cornfield (1956) who showed the equivalence
of prospective- and retrospective-odds ratios. The ef-
ficiency of the approach was established in two other
classic papers by Andersen (1970) and Prentice and
Pyke (1979), who showed that the prospective analy-
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sis of case-control data yields the proper maximum-
likelihood estimates of the odds ratio parameters of the
logistic model under a “semiparametric” setup that al-
lows the distribution of the underlying covariates to
remain completely unrestricted. More recently, it has
been shown that even in the presence of missing data
and measurement error in covariates, the “prospec-
tive” treatment of case-control data can yield proper
maximum-likelihood estimates as long as the distribu-
tion of the underlying covariates is allowed to remain
unrestricted (Roeder, Carroll and Lindsay, 1996).
A special feature for studies in genetic epidemiology
is that it is often reasonable to assume certain models
for the population distribution of the genetic and envi-
ronmental covariates of interest. The Hardy–Weinberg-
Equilibrium (HWE) law, for example, which implies a
simple relationship between allele and genotype fre-
quencies at a given chromosomal locus, is a natural
model for a random mating, large, stable population in
the absence of new genetic mutations, inbreeding and
selective survivorship among genotypes (see Hartl and
Clark, 2007, Chapter 3). Genes which are physically
apart and hence are not expected to be in linkage dise-
quilibrium (LD) are also expected to be independently
distributed in a homogeneous population. It is often
also natural to assume a subject’s genetic susceptibil-
ity, a factor which is determined at birth, is indepen-
dent of his/her subsequent environmental exposures.
A pertinent question then is what is the most appropri-
ate method for analysis of case-control data in genetic
epidemiology where some natural model assumptions
exist for the distribution of genetic and environmental
factors in the underlying population.
We will assume data on some genetic (G) and envi-
ronmental (E) exposures are collected in a case-control
study involving N0 controls (D = 0) and N1 cases
(D = 1). If one ignores the retrospective nature of the
case-control design, one can conduct inference based
on the prospective-likelihood
LP =
N∏
i=1
pr(Di |Gi,Ei),(1)
where N = N1 + N0. The fundamental likelihood for
case-control data, however, known as the “retrospec-
tive” likelihood, is given by
LR =
N∏
i=1
pr(Gi,Ei |Di).(2)
In the absence of any missing data, it is evident from
the classical theory that the prospective-likelihood (1)
provides a valid way of testing and estimation of
the odds ratio association parameters of the underly-
ing logistic regression model. In fact, the prospective-
likelihood yields the same maximum-likelihood esti-
mates for the odds ratio association parameters that
could be obtained by maximization of the proper ret-
rospective likelihood (2) while allowing pr(G,E), the
joint distribution of G and E, to remain completely
non-parametric. Under constraints on pr(G,E), how-
ever, the retrospective likelihood would not yield the
same maximum-likelihood estimator as that from the
prospective likelihood. More importantly, the retro-
spective-likelihood can exploit various population ge-
netics model assumptions such as HWE, gene–gene
and gene–environment independence to gain major ef-
ficiency over the prospective-likelihood for inference
on various association and interaction parameters. At
the same time, if the underlying model assumptions
are violated, then the use of the retrospective likeli-
hood can lead to serious bias for both testing and es-
timation procedures. In the presence of missing data, a
further complication is that the use of the prospective
likelihood may not be even strictly valid in certain set-
tings, such as that described in Section 4 for estimation
of haplotype effects, where for the purpose of identifi-
ability LP also requires some modeling assumptions,
thus destroying its equivalence with LR that is known
to hold under unspecified covariate distribution. Thus,
to date, a debate remains about the most appropriate
method of analysis of case-control studies in genetic
epidemiology.
In this article we will review some modern devel-
opments for analysis of case-control studies in genetic
epidemiology using the prospective- and retrospective-
likelihoods. We will describe the methods primarily
through two different types of applications: (a) as-
sociation testing for genotyped and imputed single
nucleotide polymorphisms (SNP) (Sections 2 and 3)
and (b) estimation of haplotype effects and haplotype–
environment interactions in the presence of phase am-
biguity (Section 4). In each section we aim to provide
new intuitive insights into the alternative methods by
constructions of various score tests (Sections 2 and 3)
and pseudo-likelihoods (Section 4). As a byproduct,
in Section 3 we also propose a novel “retrospective”
method for association testing for untyped SNPs which
can easily use any external algorithm for imputation
of genotypes. In each section we will use numerical
examples to illustrate the bias and efficiency trade-
off between the alternative methods. We will conclude
the article with a discussion and recommendations for
practical data analysis.
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2. ASSOCIATION ANALYSIS FOR SINGLE
NUCLEOTIDE POLYMORPHISMS (SNPS)
2.1 The Prospective Approach
The genotype information for an individual SNP in
a case-control study can be represented by the 2 × 3
contingency table defined by cross-tabulation of case-
control and genotype status. Let D be the indicator of
case (D = 1) or control (D = 0) status and let G be
the number of minor alleles carried by an individual
(G = 0,1,2). Let ndg denote the number of subjects
with genotype G = g and disease status D = d ob-
served in the case-control sample. Suppose we are in-
terested in testing the association of the disease out-
come with a SNP-genotype using a population logistic
regression model of the form
pr(D = 1|G) = exp{α + β
Tm(G)}
1 + exp{α + βTm(G)} ,(3)
where the function m(·) is chosen in a suitable way to
reflect an assumed mode of genetic effect. If, for exam-
ple, G denotes the count for the minor allele at a SNP
locus, then one can chose m(G) = G, m(G) = I (G ≥
1) or m(G) = I (G = 2) to model the effect of the mi-
nor allele as additive (in the logistic scale), dominant or
recessive. One can also consider a saturated model by
allowing m(G) to be a vector of two dummy variables
associated with heterozygous (G = 1) and homozy-
gous variant (G = 2) genotypes and β to be the corre-
sponding log-odds-ratios. The prospective analysis of
case-control data yields an asymptotically unbiased es-
timate for the genotype-odds-ratio parameters β , but
not for the intercept parameter α.
The score function for β under the prospective-
likelihood (1) can be written as
UPL =
N1+N0∑
i=1
m(Gi){Di − pr(D = 1|Gi)}.
Under the null hypothesis, β = 0, we can estimate p =
pr(D = 1|Gi) as p̂ = N1/(N1 + N0) since under that
hypothesis, G does not influence D. Then the score
function can be written as
U0PL =
N1∑
i=1
m(Gi)− N1
N1 +N0
N1+N0∑
i=1
m(Gi)
= N1N0
N1 +N0
{
1
N1
N1∑
i=1
m(Gi)− 1
N0
N1+N0∑
i=N1+1
m(Gi)
}
,
which is proportional to the difference between the em-
pirical means of m(G) in the cases (D = 1) and in the
controls (D = 0). We suppose without loss of general-
ity that the indices for the cases are {i = 1, . . . ,N1} and
those for the controls are {i = N1 + 1, . . . ,N1 + N0}.
If, for example, we assume m(G) = G, that is, the
additive effect, then U0PL corresponds to the numera-
tor of the Cochran–Armitage trend test (van Belle et
al., 2004, Chapter 7) that is widely used for single-
SNP association testing. More generally, a “prospec-
tive” score-test can be constructed under any genetic
model based on U0PL and its variance under the null
hypothesis of no association that be estimated by
V 0PL =
N1N0
N1 +N0Vm(G),
where Vm(G) is the pooled-sample variance of m(Gi).
2.2 Retrospective Approach
The retrospective likelihood, LR , for the genotype
data of a single-SNP can be written as the product of
two sets of multinomial probabilities:
LR = L1 ×L0 =
2∏
g=0
p
n1g
1g ×
2∏
g=0
p
n0g
0g ,
where pdg = pr(G = g|D = d), d = 0 and 1, denotes
the population genotype frequencies for the controls
and the cases, respectively. Given the genotype prob-
abilities for the controls, we can characterize the geno-
type probabilities for the cases according to the for-
mula (Satten and Kupper, 1993)
p1g = ψg(β)p0g∑2
g=0 ψg(β)p0g
,(4)
where ψg(β) denotes the odds ratio associated with the
genotype G = g as specified by the logistic model (3).
Thus, the retrospective likelihood can be parameterized
in terms of the genotype probabilities of the controls
and the disease-odds-ratio parameters β . The maxi-
mization of the retrospective likelihood LR , without
imposing any further constraints on the genotype prob-
abilities for the controls, will lead to the same estimator
for β that would be obtained by maximization of LP
(Prentice and Pyke, 1979). In fact, it can be shown that
the retrospective- and prospective-profile likelihoods
of β become identical after maximization of the corre-
sponding likelihoods with respect to the associated nui-
sance parameters (Roeder, Carroll and Lindsay, 1996).
Thus, the associated tests, including score-, Wald- and
likelihood-ratio tests, are identical under the retrospec-
tive and prospective likelihoods.
Now suppose we are willing to assume that HWE
holds in the underlying population and that the disease
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is rare so that HWE also holds approximately in the
control population. In the retrospective likelihood LR ,
we can write the genotype probabilities for the controls
as a function of the frequency, f , of the minor allele as
p00(f ) = (1 − f )2, p01(f ) = 2f (1 − f ),
p02 = f 2.
It is easy to show that the score function for β asso-
ciated with the retrospective likelihood can be written
as
URL =
N1∑
i=1
[m(Gi)−EHWE,f {m(G)|D = 1}],
which under the null hypothesis of no association re-
duces to
U0RL =
N1∑
i=1
[m(Gi)−EHWE,f {m(G)}].(5)
Moreover, under the null hypothesis, the allele fre-
quency f can be substituted for by its maximum-
likelihood estimate
f̂ = n+1 + 2n+2
2N
,(6)
where n+g denotes the frequency for genotype G = g
in the pooled sample of cases and controls. Thus, U0RL
corresponds to the difference between the empirical
mean of the function m(G) in cases and its expected
value under HWE and the null hypothesis of no asso-
ciation. In contrast, note that U0PL corresponds to the
difference between the empirical mean of the func-
tion m(G) in cases and the empirical mean for the
same function in the controls. If the expectation in the
retrospective score function (5) is estimated empiri-
cally without assuming HWE, then, as expected, it can
be easily shown that the retrospective and prospective
scores are the same. If, however, we assume HWE to
evaluate the retrospective score function, then it would
have smaller variance than that for the prospective
score. In particular, this can be seen from the estimate
of the variance estimate U0RL given by
V 0RL = N1
{
Vm(G) − N12N fˆ (1 − fˆ )C(fˆ )C(fˆ )
T
}
,
where
C(f ) = covHWE,f
{
m(G),
G− 2f
f (1 − f )
}
=∑
g
m(g)
g − 2f
f (1 − f )p0g(f ).
By the Cauchy–Schwarz inequality, V 0RL ≥ V 0PL as-
ymptotically, implying that the retrospective score test
is asymptotically more powerful than its prospective
counterpart when the assumption of HWE is valid.
Chen and Chatterjee (2007) compared the perfor-
mance of 2 d.f. Wald-tests of association based on
the retrospective and prospective likelihoods. They ob-
served major gains in power for the test based on the
retrospective-likelihood for the detection of nonmulti-
plicative effects, for example, recessive effects. Notice
that if we assume an additive model, that is, m(G) =
G, then the prospective and retrospective score func-
tions U0RL and U0PL become identical because in this
case EHWE,f̂ {m(G)} = 2f̂ =
∑N
i=1 Gi/N . The larger
the departure of the effect of a SNP from the addi-
tive form, the greater the gain in efficiency for the ret-
rospective method. Application of retrospective meth-
ods for association testing, however, requires caution
because of their sensitivity to the underlying model as-
sumption. In particular, it can be seen from the formula
of U0RL that the unbiasedness of that score function
crucially depends on the assumption of HWE being
correct for the underlying population. Satten and Ep-
stein (2004) and Chen and Chatterjee (2007) have
noted that even modest violation of HWE can cause se-
rious inflation in Type-I error in association tests based
on the retrospective likelihood.
2.3 Empirical-Bayes Methods
Luo et al. (2009) considered an empirical-Bayes
type shrinkage estimation approach to develop a 2 d.f.
single-SNP association test that can gain power by ex-
ploiting the model assumptions of HWE for the un-
derlying population and yet is resistant to bias when
the model assumptions are violated. The method in-
volves estimation of genotype-specific disease odds
ratio parameters by data-adaptive “shrinkage” of a
“prospective” model-free estimator that does not re-
quire the HWE assumption toward a “retrospective”
model-based estimator that directly exploits the HWE
constraints. The amount of “shrinkage” is sample-size
and data-adaptive, so that in large samples the method
has no bias whether the assumption of HWE holds or
not and yet the method can gain efficiency by shrinking
the analysis toward HWE, but only to the extent that
the data validate the assumptions. In what follows we
provide some insight into the empirical-Bayes method
through the construction of a score-test. For numerical
illustration, however, we will focus on the Wald test as
originally developed in Luo et al. (2009).
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Let m(G) = (N1 + N0)−1∑N1+N0i=1 m(Gi)
and s2m(G) = (N1 + N0)−1
∑N0+N1
i=1 {m(Gi) − m(G)}2
denote the sample mean and variance for the func-
tion m(G), respectively. Further, let τ̂ = m(G) −
Ef̂ ,HWEm(G) denote the difference between the em-
pirical and expected means of m(G) when the latter
quantity is computed assuming HWE and under the es-
timate of allele frequency f̂ given in (6). Intuitively, τ̂
can be viewed as an estimate of the bias in estimation
of the population mean of m(G) under the assumption
of HWE. An empirical-Bayes type score function can
be now defined as
U0EB =
N1∑
i=1
[m(Gi)−EEB{m(G)}],(7)
where EEB{m(G)} is the empirical-Bayes estimate for
the mean of the function m(G) under H0, given by
EEB{m(G)} =
s2m(G)/N
s2m(G)/N + τ̂ 2
EHWE,f̂ {m(G)}
+ τ̂
2
s2m(G)/N + τ̂ 2
m(G).
Thus, EEB{m(G)} corresponds to a weighted average
of the empirical mean of m(G) and its expected mean
under HWE, with the weights defined by an estimate
of the bias for the estimate of the population mean of
m(G) under HWE and an estimate of the variance of
the empirical mean of m(G). As τ̂ 2 decreases, that is,
the evidence of bias due to the violation of HWE be-
comes smaller, EEB{m(G)} gives more weight to the
more precise HWE-based estimator of the population
mean of m(G). Conversely, as s2m(G)/N decreases, that
is, the sample mean of m(G) becomes more precise,
then EEB{m(G)} puts more weight to the robust model-
free estimator m(G). The original perspective for con-
structing such weighted combinations of model-based
and model free estimators from an empirical-Bayes
point of view can be found in Mukherjee and Chatter-
jee (2008). Simple methods for variance estimation for
such estimators have been also described in that article.
2.4 The Cancer Genetics Markers of Susceptibility
(CGEMS) Study
We illustrate the performance of alternative 2 d.f.
single SNP association tests using data from the Can-
cer Genetics Markers of Susceptibility (CGEMS) study
(Yeager et al., 2007; Hunter et al., 2007; Thomas et
al., 2008), an NCI enterprize initiative to conduct mul-
tistage whole-genome association studies to identify
TABLE 1
The empirical proportions of significant SNPs detected by different
methods at different nominal significance levels in the CGEMS
prostate cancer study
α Prospective Retrospective Empirical-Bayes
5e–2 5.01e–2 5.66e–2 4.49e–2
1e–2 0.98e–2 1.43e–2 0.87e–2
1e–3 1.05e–3 3.85e–3 1.00e–3
1e–4 1.27e–4 2.24e–3 1.31e–4
1e–5 2.67e–5 1.76e–3 3.34e–5
1e–6 2.22e–6 1.47e–3 4.45e–6
susceptibility genes giving rise to increased risks of
prostate and breast cancers. In this article we will fo-
cus on data from the initial scan for the prostate cancer
study, involving genotype data on about 550,000 SNPs
from 1172 cases and 1157 controls. The details of the
CGEMS study design and the results from the initial
scan and subsequent replication studies can be found
at the web site https://caintegrator.nci.nih.gov/cgems/.
We consider 449,698 SNPs from 22 nonsex chromo-
somes with minor allele frequencies larger than 0.05.
Table 1 displays the empirical proportions of the num-
ber of SNPs that are found to be significant at differ-
ent nominal significance levels using 2 d.f. tests based
on three different methods: (a) prospective, (b) retro-
spective and (c) empirical-Bayes [see Luo et al. (2009)
for more details]. For a well-designed study and a ro-
bust analytic method, the empirical proportions are ex-
pected to be fairly close to the nominal significant lev-
els, given that the vast majority of the SNPs are likely
to be not associated with the disease. In Table 1, we
observe that the empirical proportions of significant
SNPs found by the prospective method closely follows
the nominal significance levels. In contrast, the cor-
responding proportions for the retrospective test devi-
ate severely from the nominal values in the range of
α ≤ 10−3, indicating significantly inflated type-I error
due to the violation of HWE for many SNPs. The last
column of Table 1 shows that the empirical-Bayes pro-
cedure essentially corrects for all the bias of the retro-
spective method due to the violation of the HWE as-
sumption.
Next, we conducted a simulation study to inves-
tigate the performance of various tests in ranking a
true susceptibility locus in a genome-wide association
study (GWAS) that include hundreds of thousands of
“null” SNPs. To generate realistic linkage disequilib-
rium patterns, we simulated GWAS data mimicking
the CGEMS study itself. Given minor allele frequency
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among controls and the disease-genotype odds ratio
parameters for a chosen susceptibility locus, we sim-
ulate genotype data at that locus for the cases and
controls separately from the corresponding multino-
mial distributions. Given the genotype data at the sus-
ceptibility locus for a case or a control, we simulate
genotype data for the remainder of the SNPs by as-
signing the whole genotype profile for a randomly se-
lected subject from the controls of the CGEMS study
who have the same genotype data at the given suscep-
tibility locus as the sampled subject in our simulation
study. This algorithm, as originally described by Yu et
al. (2009), assumes that given the genotypes for the
susceptibility locus, the risk of the disease is indepen-
dent of all the remaining SNPs. We simulated 50 data
sets with approximately 550 cases and 550 controls.
For each data set we tested for association for each
of the approximately 450,000 SNPs using the prospec-
tive, retrospective and empirical-Bayes methods. The
rank of the disease-associated SNP is obtained by sort-
ing all the p-values in ascending order.
Table 2 displays the median ranks obtained by three
methods for a true disease-associated SNP that has a
recessive effect with a log-odds-ratio of β = log(3).
As expected, the ranks of all tests decrease as the mi-
nor allele frequency increases. Comparing the ranks of
different tests at a specific minor allele frequency, we
can see that the standard prospective method generally
has the lowest power in the sense that it assigns much
higher rank to the susceptibility SNP than the two other
tests. When minor allele frequency is 0.1, we observe
that the pure retrospective method performs the best in
the sense that it assigns the lowest rank to the suscep-
tibility SNPs among all the methods. In contrast, when
minor allele frequency is greater than or equal to 0.2,
we observe that the empirical-Bayes procedure assigns
considerable lower rank to the susceptibility SNP than
the pure retrospective method. Intuitively, the results
TABLE 2
Simulated median ranks of a true susceptibility SNP with a
recessive effect and log-odds-ratio value of log(3) for alternative
tests. The results are based on 50 simulated datasets, each of
which has approximately 550 cases and 550 controls and 450,000
SNPs. MAF: minor allele frequency
MAF Prospective Retrospective Empirical-Bayes
0.1 112163 8117 44319
0.2 1888 203 52
0.3 656 210 27
0.4 15 82 2
can be explained from the fact that the retrospective
method yields low p-values for many null SNPs due to
the violation of the HWE assumption (see Table 1) and
thus dilutes the rank of the real susceptibility SNP.
3. ASSOCIATION ANALYSIS FOR IMPUTED SNPS
The forms of the prospective- and retrospective-
scores suggest how they can be modified easily for
SNPs that may not have been directly genotyped, but
can be “imputed” conditional on neighboring SNPs
and estimates of linkage disequilibrium from HapMap
or other similar databases. Let N (G) denote the neigh-
boring genotype information for an untyped SNP-locus
with unobserved genotype G. The prospective score
for such an untyped SNP can be defined by taking the
conditional expectation of the “complete data” score
function U0PL given the observed data, that is, the
neighboring genotype information. More formally, the
prospective score for an untyped SNP can be written as
U0uPL =
N1N0
N1 +N0
[
1
N1
N1∑
i=1
E{m(G)|N (Gi)}
(8)
− 1
N0
N0∑
i=1
E{m(G)|N (Gi)}
]
,
where the conditional expectations are taken with re-
spect to a suitable imputation model such as those de-
scribed by Nicolae (2006), Marchini et al. (2007) and
others. The retrospective score for an untyped SNP can
be similarly defined by the conditional expectation of
the “complete data” retrospective score function U0RL
given the observed data N (G) in the form
U0uRL =
N1∑
i=1
[E{m(G)|N (Gi)}
(9)
−EHWE,f {m(G)}].
Notice that in the retrospective score function, the con-
tribution of the term EHWE,f {m(G)} is a constant term
given the allele frequency f . The estimation of the
allele frequency f for an untyped SNP, however, re-
quires imputation. In particular, under the “complete
data” model we can write the estimate of the allele fre-
quency under the null hypothesis of no association as
f̂ =
∑N0+N1
i=1 {I (Gi = 1)+ 2I (Gi = 2)}
2N
.
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Thus, given an imputation model, we can estimate the
allele frequency f as
f̂ u =
(
N0+N1∑
i=1
pr{G = 1|N (Gi)}
(10)
+ 2pr{G = 2|N (Gi)}
)/
(2N).
We further need the variances for U0uPL and U0uRL
under the null hypothesis to obtain the corresponding
score tests. The variance of U0uPL can be estimated as
V 0uPL =
N1N0
N1 +N0VE{m(G)|N (G)},
where VE{m(G)|N (G)} is the pooled-sample variance of
E{m(G)|N (Gi)}. The prospective-score test is based
on the test statistic given by
(U0uPL)
T{V 0uPL}−U0uPL,
where the superscripts T and—denote transpose and
generalized inverse, respectively. Asymptotically, this
statistic follows a chi-squared distribution under the
null hypothesis of β = 0, with the degrees of freedom
given by the dimension of m(G). The variance of the
retrospective score U0uRL, after adjusting for the estima-
tion of the allele frequency f by f̂ given by (10), can
be estimated by
V 0uRL = N1
[
VE{m(G)|N (G)}
+ N1
2N
{
VE{G|N (G)}
2
C(fˆ )C(fˆ )T
−QC(fˆ )T −C(fˆ )QT
}]
,
where Q is the pooled-sample covariance between
E{m(G)|N(Gi)} and E{G|N(Gi)}. The variance of
U0uRL can also be alternatively estimated by the robust
sandwich-type estimate given as
V 0uPL =
N1+N0∑
i=1
U˜0uRL,i(U˜
0u
RL,i)
T,
where the efficient score
U˜0uRL,i = Di[E{m(G)|N (Gi)} −EHWE,f̂ {m(G)}]
− N1
2N
C(f̂ )[E{G|N (Gi)} − 2f̂ ].
The retrospective-score test is then based on the test
statistic given by
(U0uRL)
T{V 0uRL}−U0uRL,
which again follows a chi-squared distribution asymp-
totically under the null hypothesis, with the degrees of
freedom given by the dimension of m(G). In both the
prospective- and retrospective-score tests given above,
we obtain the conditional probability Pr{G|N (Gi)} di-
rectly from some external reference database, for ex-
ample, HapMap, a strategy similar to the proposal of
Nicolae (2006).
We now demonstrate the potential power advantages
that might be achieved by imputing the untyped SNP,
using numerical studies following two scenarios as in
Tables 1 and 2 of Nicolae (2006). In Scenario 1 the un-
typed SNP can be perfectly predicted by the genotypes
of the typed SNPs, namely, the R2s = 1 (see Stram et
al., 2004, for a definition), while in Scenario 2 the un-
typed SNP is moderately predicted by the genotypes of
the typed SNPs with R2s = 0.39. The SNP profiles to-
gether with the haplotype frequencies estimated from
HapMap CEU samples in the two scenarios are sum-
marized in Tables 3 and 4. Also listed in Tables 3 and 4
are the haplotype frequencies we actually used to sim-
ulate the SNP data for the case-control sample, which
moderately deviate from those seen in the HapMap
CEU sample to reflect the potential discrepancy be-
tween the HapMap and study samples. The haplotype
pair for each person is generated according to HWE.
We simulated the case-control status by the logistic
regression model (3), where the genetic determinant G
is given by the minor allele count of the untyped SNP,
and the function m(·) is given by the recessive, domi-
nant or additive genetic mode. The intercept α = −3.0,
which yields an overall disease rate around 5%. Each
analysis is based on a case-control sample with 1000
cases and 1000 controls. The simulation results are
based on 1000 (3000) repetitions for evaluation of test
TABLE 3
The SNP profiles and haplotype frequencies for the region
considered in Scenario 1, where the untyped SNP can be perfectly
predicted by genotyped SNPs A1, . . . ,A4 (R2s = 1). Also listed are
the haplotype frequencies estimated from the CEU sample in
HapMap. Part of the data are from Table 1 of Nicolae (2006)
Haplotype of SNPs Frequency
A1–T –A2–A3–A4 Frequency from HapMap
1–0–0–0–0 0.158 0.058
0–1–0–1–0 0.400 0.300
1–1–0–1–0 0.050 0.050
1–1–1–0–1 0.358 0.558
0–1–1–0–1 0.022 0.017
1–1–0–0–1 0.012 0.017
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TABLE 4
The SNP profiles and haplotype frequencies for the region
considered in Scenario 2, where the untyped SNP is moderately
predicted by genotyped SNPs A1, . . . ,A3 (R2s = 0.39). Also listed
are the haplotype frequencies estimated from the CEU sample in
HapMap. Part of the data are from Table 2 of Nicolae (2006)
Haplotype of SNPs Frequency
A1–T –A2–A3 Frequency from HapMap
0–0–0–0 0.088 0.058
0–0–1–1 0.027 0.017
0–1–0–0 0.302 0.342
0–1–1–0 0.008 0.008
1–0–1–0 0.242 0.142
1–0–1–1 0.333 0.433
power (size). All the tests are performed at a signifi-
cance level of 0.01. The score tests are performed using
the correct genetic model, and the retrospective-score
tests are based on the robust sandwich-type variance
estimates; results based on model-based variance es-
timates are quite similar and are omitted. When per-
forming the prospective- and retrospective-score tests
with imputed genotypes for the untyped SNP, we use
the haplotype frequency estimates from HapMap to ob-
tain the conditional probabilities Pr{G|N (Gi)}, even
though the case-control sample is actually from a pop-
ulation with moderately different haplotype frequen-
cies. To see the degree of recovery of missing infor-
mation achieved by imputation, we also perform the
prospective- and retrospective-score tests based on the
true genotypes at the untyped SNP. In addition, we
perform the multimarker Hotelling’s T 2 test based on
genotypes at typed SNPs (Xiong, Zhao and Berwinkle,
2002; Chapman et al., 2003), which is equivalent to the
prospective-score test derived from the logistic regres-
sion model (3) with the covariates m(G) given as the
vector of genotypes for all the typed SNPs.
Results for this simulation study are presented in Ta-
bles 5 (Scenario 1) and 6 (Scenario 2). It is seen that the
score tests with imputed genotypes have size matching
reasonably well with the nominal value of 1%, even
though the imputation is based on haplotype frequen-
cies that are obtained from the HapMap data and are
different from the true frequencies. From the results re-
garding power, we see that imputing the untyped SNP
in either the prospective- or the retrospective-score test
can achieve substantial power gains as compared with
the Hotelling’s T 2 test based only on genotyped SNPs.
The relative power improvement gained by imputation
can still be quite remarkable even when the accuracy
for predicting the untyped SNP using the genotyped
SNPs is only of a moderate level (Scenario 2, where
R2s = 0.39). On the other hand, the prediction accu-
racy does affect the degree of recovery of the miss-
ing information that may be achieved by imputation:
in Scenario 1, with perfect prediction of the untyped
SNP, the tests using imputed genotypes do attain the
full power we would obtain if the tests were based on
the true genotype of the untyped SNP. In Scenario 2,
with moderate prediction of the untyped SNP, imputa-
tion of the untyped SNP can recover partial but not full
power. It is worth remembering that, with exact data,
the retrospective-score test is usually more powerful
than the prospective-score under the dominant or reces-
sive model, and the two tests are essentially equivalent
under the additive model. Here we observe the same
phenomena when the prospective- and retrospective-
score tests are based on imputed genotypes.
As we noted earlier, when exact genotype data are
available, the retrospective-score test is more sensi-
tive to violation of the HWE assumption than the
prospective-score test; that is, the former is usually
biased while the latter still remains unbiased when
HWE does not hold. To assess the robustness proper-
ties for the prospective- and retrospective-score tests
with imputed genotype data, we performed a further
simulation study where the SNP haplotypes are still
given as in Tables 3 and 4, but the haplotype pair
H di = (ha, hb) for each person is given by the model
with Pr{H di = (ha, hb)} = (1−ζ )θaθb for ha = hb and
Pr{H di = (ha, hb)} = ζθa + (1 − ζ )θ2a for ha = hb,
where θa is the frequency for haplotype ha , and ζ , the
fixation index quantifying the departure from HWE, is
set to 0.05. We can see from the results listed in Table 7
that, with imputed genotype data, the prospective-score
test, like its exact-data counterpart, still shows greater
robustness in maintaining the type-I error rates than the
retrospective-score test. In particular, the retrospective-
score test, based on the recessive or dominant model,
may yield high type-I error rates under violation of
HWE, no matter whether exact or imputed genotype
data are used. Thus, an empirical-Bayes type shrinkage
method that can adapt between prospective and retro-
spective methods depending on bias-variance trade-off
could be useful for analysis of both typed and untyped
SNPs.
We conclude this section with a discussion on the
two types of association analyses recently developed
for untyped SNPs: the full likelihood approach (Lin,
Hu and Huang, 2008) and the two-stage approach
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TABLE 5
Size/Power (%) of the prospective- and retrospective-score tests (significance level = 0.01) based on the imputed and true (in parenthesis)
genotypes at the untyped causal SNP, using SNP data generated according to Table 3 (perfect prediction). Also shown are results for the
Hotelling’s T 2 test based only on genotypes at the typed SNPs. Results for power (size) are based on 1000 (3000) simulated data sets
Prospective score Retrospective score Hotelling’s T 2
β imputed (true) imputed (true)
Recessive model
0 1.1 (1.1) 1.1 (1.1) 0.9
0.5 26.1 (26.1) 33.7 (33.7) 3.6
0.6 40.1 (40.1) 55.3 (55.3) 5.6
Dominant model
0 1.0 (1.3) 1.0 (1.3) 0.9
0.3 68.6 (68.6) 72.9 (72.9) 39.0
0.4 96.0 (96.0) 96.7 (96.7) 79.3
Additive model
0 1.2 (1.2) 1.2 (1.2) 0.9
0.2 43.0 (43.0) 43.0 (43.0) 24.2
0.3 86.4 (86.4) 86.4 (86.4) 65.5
(Nicolae, 2006; Marchini et al., 2007). The full like-
lihood approach uses a retrospective likelihood for the
case-control sample and a likelihood for the external
(such as HapMap) data, by which the imputation and
association analysis are simultaneously performed in a
one-stage manner. Conversely, the two-stage approach
performs the imputation and association analysis sep-
arately: imputing missing genotypes in the first stage
and then performing association analysis in the sec-
ond stage. In the imputation stage of the two-stage ap-
proach, one can apply existing powerful external impu-
tation algorithms such as Nicolae (2006) and Marchini
et al. (2007), and, hence, the two-stage approach is con-
venient to implement. There has been some debate on
the efficiency difference between the two approaches
(Marchini and Howie, 2008; Lin and Hu, 2008). Our
simulation results (Tables 5 and 6) suggest that some
of the efficiency difference between the full likelihood
and the two-stage approaches may be due to the use
of different likelihoods (prospective vs. retrospective)
TABLE 6
Size/Power (%) of the prospective- and retrospective-score tests (significance level = 0.01) based on the imputed and true (in parenthesis)
genotypes at the untyped causal SNP, using SNP data generated according to Table 4 (moderate prediction). Also shown are results for the
Hotelling’s T 2 test based only on genotypes at the typed SNPs. Results for power (size) are based on 1000 (3000) simulated data sets
Prospective score Retrospective score Hotelling’s T 2
β imputed (true) imputed (true)
Recessive model
0 1.4 (1.2) 1.2 (1.2) 1.1
0.5 42.6 (92.2) 47.0 (97.6) 17.6
0.6 59.4 (99.1) 66.4 (99.9) 24.9
Dominant model
0 0.8 (1.1) 0.9 (1.0) 1.1
0.4 48.5 (95.6) 54.3 (98.2) 23.8
0.5 71.6 (99.6) 77.2 (100) 41.5
Additive model
0 1.0 (1.3) 1.0 (1.3) 1.1
0.3 60.2 (97.6) 60.1 (97.6) 40.6
0.4 92.5 (99.9) 92.4 (99.9) 77.4
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TABLE 7
Size (%) of the prospective- and retrospective-score tests
(significance level = 0.01) based on the imputed and true (in
parenthesis) genotypes at the untyped causal SNP, using SNP data
generated according to Scenarios 1 (Table 3) and 2 (Table 4) and
a fixation index of 0.5 (violating HWE). Results are based on 3000
simulated data sets
Prospective score Retrospective score
imputed (true) imputed (true)
Recessive model
Scenario 1 0.8 (0.8) 1.7 (1.7)
Scenario 2 1.2 (1.2) 5.9 (7.7)
Dominant model
Scenario 1 0.9 (0.9) 1.4 (1.4)
Scenario 2 1.0 (0.8) 3.2 (5.1)
Additive model
Scenario 1 1.0 (1.0) 1.0 (1.0)
Scenario 2 0.7 (0.8) 0.7 (0.8)
and not so much due to the use of one-stage vs. two-
stage analysis. In this section we have shown that one
can still use a retrospective likelihood even in a two-
stage approach with powerful imputation performed at
the first stage.
4. HAPLOTYPES
4.1 Definitions, Background and Missing Data
Although single-SNP association tests are often the
primary methods for genome-wide association scans,
many secondary or “downstream” analyses are often
useful for detailed characterization of the risk of the
disease associated with specific genomic regions of in-
terest. One popular technique is haplotype-based as-
sociation analysis, which involves studying the asso-
ciation of a disease with a genomic region in terms of
the underlying “haplotypes,” the combination of alleles
at multiple loci along individual homologous chromo-
somes. Originally, haplotype-based association analy-
sis was considered a powerful technique for “indirect”
association testing in situations where a causal SNP
may not have been genotyped, but the haplotypes de-
fined by multiple typed SNPs could serve as a good
“surrogate” for the causal variant. With the advent of
various imputation methods, although haplotype analy-
sis has become less relevant for such indirect associa-
tion testing, it remains a useful tool for parsimonious
characterization of disease risk associated with mul-
tiple, possibly interacting, loci within a given region.
Moreover, it is conceivable that for some regions, the
haplotypes, and not the individual SNPs, are functional
units and, thus, for these regions stronger signals of as-
sociations could be detected by performing haplotype-
based regression analysis.
A technical problem for haplotype-based regression
analysis is that typically the haplotype information for
the study subjects is not directly observable. Instead,
locus-specific genotype data are observed, which con-
tain information on the pair of alleles a subject carries,
but does not provide the “phase information,” that is,
which combinations of alleles appear across multiple
loci along the individual chromosomes. In general, the
genotype data of a subject will be phase-ambiguous
whenever the subject is heterozygous at two or more
loci. Statistically, the lack of phase information can be
viewed as a special missing data problem.
For example, suppose A/a and B/b denote the ma-
jor/minor alleles in two bi-allelic loci. A particular hap-
lotype pair, called a diplotype, is the pair of alleles that
are inherited from one’s parents. One such haplotype
pair would be (AB) − (ab), and disease risk can be
associated with the number of copies of particular hap-
lotypes that one inherits. Unfortunately, the diplotypes
are not observable directly, but instead we can observe
only the unordered or combined genotypes, in this case
(Aa) at the first locus and (Bb) at the second locus, that
is, (AaBb). However, when observing only the geno-
types, the actual haplotype pair is unknown, or “phase
ambiguous,” because the haplotype pair (Ab) − (aB)
has the same set of unordered genotypes. Confronted
with the unordered set of genotypes (AaBb), we know
that the actual haplotype pair is either (AB) − (ab) or
(Ab) − (aB), but we must use probability models to
take into account the phase ambiguity when perform-
ing statistical inference.
In Section 2 we described “model-free” prospective
and “model-based” efficient retrospective methods for
analyzing SNP data, and we also described empirical-
Bayes methods that data-adaptively move between the
two. Just as in SNP data, for haplotype data there are
also model-free and model-based methods, and accom-
panying empirical-Bayes methods.
A variety of methods have been developed for
haplotype-based analysis of case-control data using the
logistic regression model (Zhao, Li and Khalid, 2003;
Lake et al., 2003; Epstein and Satten, 2003; Satten and
Epstein, 2004; Spinka, Carroll and Chatterjee, 2005;
Lin and Zeng, 2006; Chatterjee et al., 2006; Chen,
Chatterjee and Carroll, 2009). Consider a general risk
model similar to (3) but with the addition of environ-
mental factors (E) and written in terms of the diplo-
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types, denoted as H di:
pr(D = 1|H di,E)
(11)
= exp{α +m(H
di,E,β)}
1 + exp{α +m(H di,E,β)} ,
where the function m(·) is chosen in a suitable way
to reflect an assumed mode of genetic effect. For ex-
ample, suppose we are interested in the particular hap-
lotype h∗ = (ab). A model that assumes an additive
effect of this haplotype would have m(H di = hdi,E)
linear in the number of copies of the haplotype h∗.
4.2 Model-Based and Model-Free Methods
4.2.1 Identifiability. The data setup then is that we
have observations on environmental exposure (E),
genotypes G and cases and controls D. What is miss-
ing is the underlying diplotype H di. The retrospective
likelihood is still (2), but the risk of disease depends on
the diplotype H di and not otherwise on the genotype.
While models such as (11) seem straightforward
enough for random samples, in retrospective samples
a problem arises because of the phase ambiguity. In
particular, all components of β may not be identifi-
able if the distribution of (H di,E) is left completely
unrestricted (Epstein and Satten, 2003; Lin and Zeng,
2006). Thus, to make progress, some type of distrib-
utional assumptions are needed. Here we will distin-
guish between two approaches, both of them retrospec-
tive in nature but with different distributional assump-
tions. The first we call “model-free” in that very little
is actually assumed about the haplotype distribution. If
haplotypes were observable, this method reduces to or-
dinary prospective logistic regression, while in the rare
disease case with phase ambiguity, the method reduces
to that of Zhao, Li and Khalid (2003). The second
approach, which we call “model-based,” makes much
stronger assumptions about the haplotype distribution,
and reduces to the efficient retrospective approach of
Chatterjee and Carroll (2005) if haplotypes were ob-
servable. The model-free method will thus be more ro-
bust but less efficient than the model-based method.
4.2.2 Model-based method. The model-based
method (Spinka, Carroll and Chatterjee, 2005) has
three aspects:
(A.1) Haplotypes and the environment are assumed in-
dependent in the population.
(A.2) The diplotypes are assumed to be in HWE in the
population, so that
pr
(
H di = hdi = (ha, hb)|E)
= q{hdi = (ha, hb), θ}
=
{
θ2a , if ha = hb,
2θaθb, if ha = hb,
where θs denotes the population frequency for
the haplotype hs .
(A.3) The distribution of the environmental variable E
is left completely nonparametric.
The methodology Spinka, Carroll and Chatterjee
(2005) used to construct their profile likelihood was
a nonparametric maximum likelihood estimator over
the unknown distribution of E. However, there is an
alternative derivation, one that is both more intuitive
and much easier to work out. Indeed, it is a not suffi-
ciently well-known fact that for most purposes a case-
control study can be viewed as a prospective study
with missing data. Consider a sampling scenario where
each subject from the underlying population is selected
into the case-control study using a Bernoulli sampling
scheme where the selection probability for a subject
given his/her disease status D = d is proportional to
Nd/pr(D = d). Inference with the actual case-control
data can then be based on the pseudo-likelihood de-
rived for such an alternative sampling scenario. Let
δ = 1 denote that a subject is selected in the case-
control sample under this Bernoulli sampling scheme
and hence has been observed. Then in this alterna-
tive sampling scheme, and with the assumptions stated
above, Spinka, Carroll and Chatterjee (2005) compute
pr(D = 1,G = g|E,δ = 1). This calculation is sim-
ple and in the rare disease case the resulting efficient
model-based likelihood function reduces to
Lmodel(D,G,E,	)
= ∑
hdi∈HG
q(hdi, θ) exp[D{κ +m(hdi,E,β)}]
(12) /( 1∑
s=0
∑
hdi
q(hdi, θ)
· exp[s{κ +m(hdi,E,β)}]
)
,
where pd = Nd/N , πd = pr(D = d), κ = α +
log(p1/p0) − log(π1/π0), 	 = (β, θ, κ), and HG is
the set of diplotypes consistent with the observed geno-
types G.
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4.2.3 Model-free method. The two important model
assumptions in the model-based estimator are (A.1)
and (A.2). Although because of identifiability some
model assumptions must be made, they can be weak-
ened tremendously, as follows (Chen, Chatterjee and
Carroll, 2009):
(B.1) The haplotype and the environment are indepen-
dent in the population given the genotype G.
(B.2) There population distribution for the diplotypes
given the genotype G, called qfree(hdi|G,θ), can
be derived assuming HWE.
Following the same alternative sampling scheme as
described in Section 4.2.2, or by doing a nonpara-
metric maximum likelihood analysis, we can compute
pr(D = 1|G,E, δ = 1) under assumptions (B.1), (B.2)
and (A.3) to be
Lfree(D,G,E,	)
= ∑
hdi∈HG
qfree(h
di|G,θ)
· exp[D{κ +m(hdi,E,β)}](13) /( 1∑
s=0
∑
hdi∈HG
qfree(h
di|G,θ)
· exp[s{κ +m(hdi,E,β)}]
)
.
To see why the likelihood Lfree requires far weaker
assumptions than Lmodel, note that Lfree requires the
haplotype–environment independence and HWE as-
sumption only to specify the conditional distribution
pr(H di|G,X), while Lmodel requires the same assump-
tion to specify the entire joint distribution pr(H di,X).
As a result, Lfree requires the haplotype–environment
independence and HWE only to resolve the phase am-
biguous genotypes. The likelihood contribution for the
subjects with phase unambiguous genotypes, that is,
G = H di, is the same as that for the standard prospec-
tive logistic regression. In contrast, Lmodel depends
on the assumptions (A.1) and (A.2) irrespective of
whether a subject has a missing phase or not.
Note that Lfree(D,G,E,	) will contain little infor-
mation on θ since it conditions on G. Thus, when im-
plementing methods based on this likelihood, Chen,
Chatterjee and Carroll (2009) proposed to replace the
score function for θ by the estimating function for θ
based on the genotype data from the controls and as-
suming that the haplotypes are in HWE in the popula-
tion.
4.3 Empirical-Bayes
In Section 4.2.2 we constructed a profile likeli-
hood under strong assumptions leading to an efficient
method that will not be robust to violations of the two
major assumptions. Conversely, in Section 4.2.3 we
computed a profile likelihood leading to much more
robust inference, but at the cost of a steep loss of effi-
ciency. Similarly to Section 2.3, here we briefly review
a fully sample size- and data-adaptive empirical-Bayes
method that Chen, Chatterjee and Carroll (2009) de-
scribed for gaining efficiency when warranted but is
still robust.
Let β̂free and β̂model be the model-free and model-
based estimates, with j th components β̂j,free and
β̂j,model. Let V be the covariance matrix of ψ̂ = β̂free −
β̂model, with the j th diagonal element of V being vj :
a sandwich estimator vj can be computed, although a
nonparametric bootstrap can also be used. Then one
can define the empirical-Bayes estimator
β̂j,EB = β̂j,free +Wj(β̂j,model − β̂j,free);
(14)
W = vj
vj + (β̂j,free − β̂j,model)2 .
The intuition behind (14) is that if the model fails,
(β̂j,model − β̂j,free) will be large relative to vj , which as
a variance is proportional to N−1, hence, Wj ≈ 0, and,
hence, the empirical-Bayes method will effectively be-
come the model-free estimator. If, however, the model
assumption holds, then vj and (β̂j,free − β̂j,model)2 are
proportional to one another, so that Wj > 0 and the
empirical-Bayes estimate goes part way toward the
model-based estimator, and hence gains efficiency over
the model-free estimate. Chen, Chatterjee and Carroll
(2009) describe the limiting distribution of (14) and
how to compute an estimate of its variance.
Chen, Chatterjee and Carroll (2009) illustrate ap-
plication of the different methods in two case-control
data examples. The examples were chosen in such a
way that from a priori biologic grounds one would
expect the gene–environment independence assump-
tion to hold in one case, but not in the other. The two
examples together illustrate how the different shrink-
age estimators adapt to alternative scenarios of gene–
environment distribution.
5. DISCUSSION
Researchers now increasingly use the Cochran–
Armitage trend test as the primary method for single-
SNP association testing in the GWAS. The test is
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known to have robust power for the detection of effect
of susceptibility SNPs under a range of realistic modes
of inheritance that give rise to some sort of monotone
relationship between disease risk and allele count. As
noted in Section 2, the retrospective and prospective
methods have very similar, if not identical, power un-
der the trend model and thus either could be used as
the primary method for analysis of GWAS data. The
trend test, however, can perform very poorly for the
detection of SNPs for which the minor allele has a re-
cessive effect. Thus, it is often recommended that a
test under the recessive mode of inheritance be con-
ducted as a secondary step to detect SNPs with reces-
sive effects that may be missed by the primary trend
test of association. The use of the retrospective method
can be potentially beneficial at this stage. One, how-
ever, has to be cautious about creation of false positive
results due to the violation of the HWE assumption.
We recommend that if a retrospective method is to be
used for potential power gain, then it should be used in
conjunction with the empirical-Bayes type shrinkage
estimation. Our numerical investigations suggest that
such a method can indeed be more powerful than the
conventional “prospective” methods without creating
excess false positives; see Tables 1 and 2.
In this article, although we focus on association tests
involving bi-allelic SNPs, the same issues are rele-
vant for genetic association tests involving loci with
more than two alleles. In particular, one can gain ef-
ficiency for analysis of case-control data by assum-
ing HWE or other natural population-genetic models
(Satten and Epstein, 2004; Lin and Zeng, 2006) to
specify multi-allelic genotype frequency for the under-
lying population. The sensitivity of the methods to un-
derlying model assumption can be reduced by appro-
priate shrinkage estimation techniques.
The impact of population stratification (PS) can be
very different for prospective and retrospective meth-
ods. As it is well known, the presence of population
stratification, that is, the existence of hidden eth-
nic sub-structures in the population, can create con-
founding bias in all of the methods when both gene-
frequency and disease risks vary across the underlying
strata. The presence of PS can also cause large scale
violation of the HWE assumption, thus making the
retrospective method more susceptible to bias than
its prospective counterpart. Our application of differ-
ent methods to the CGEMS genome-wide association
study data illustrated that the empirical-Bayes type
procedure can correct for inflated type-I error that may
exist for retrospective methods due to large scale vio-
lation of the underlying HWE assumption.
The difference between prospective and retrospec-
tive methods becomes more relevant for studies of
gene–gene and gene–environment interactions, a topic
that we have not directly addressed in this article.
In particular, retrospective methods, such as the case-
only analysis (Piegorsch, Weinberg and Taylor, 1994),
which assumes gene–gene or/and gene–environment
independence for the underlying population, can gain
dramatic power for testing and estimation of odds ra-
tio interaction parameters in the logistic regression
model. Given that standard case-control analyses of-
ten have poor power for detection of multiplicative in-
teractions due to small numbers of cases or controls
in cells of crossing exposures, practitioners often find
it is tempting to use the more powerful retrospective
methods. The assumption of gene–environment inde-
pendence, however, can be violated, either due to di-
rect casual association between gene and environment
or indirect association due to effects of family history
and hidden population stratification. The assumption
of gene–gene independence between physically distant
genes can also be violated due to population stratifi-
cation. Thus, we believe the development of shrink-
age (Mukherjee and Chatterjee, 2008; Chen, Chatter-
jee and Carroll, 2009) and other types of data-adaptive
techniques (Li and Conti, 2009) has been valuable for
robust inference in case-control studies of genetic epi-
demiology.
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